Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
CN |
|
Future Data Group Ltd
HKEX:8229
|
KR |
Cash Flow Statement
Cash Flow Statement
Hansoh Pharmaceutical Group Company Ltd
| Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||||
| Net Income |
3 001
|
2 949
|
3 098
|
3 152
|
3 300
|
3 262
|
2 948
|
2 939
|
3 766
|
5 384
|
5 085
|
5 655
|
|
| Depreciation & Amortization |
202
|
211
|
233
|
259
|
278
|
301
|
345
|
371
|
366
|
398
|
401
|
382
|
|
| Stock-Based Compensation |
0
|
0
|
69
|
111
|
65
|
75
|
179
|
214
|
171
|
153
|
138
|
149
|
|
| Other Non-Cash Items |
(164)
|
(188)
|
(135)
|
(169)
|
(254)
|
(161)
|
78
|
(189)
|
(684)
|
(726)
|
(853)
|
(869)
|
|
| Cash Taxes Paid |
541
|
539
|
590
|
550
|
319
|
231
|
324
|
517
|
590
|
714
|
807
|
697
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
9
|
3
|
0
|
|
| Change in Working Capital |
291
|
240
|
(806)
|
(1 129)
|
(748)
|
(136)
|
(630)
|
(1 008)
|
(332)
|
(404)
|
(771)
|
(383)
|
|
| Cash from Operating Activities |
3 330
N/A
|
3 213
-4%
|
2 390
-26%
|
2 113
-12%
|
2 577
+22%
|
3 267
+27%
|
2 741
-16%
|
2 114
-23%
|
3 116
+47%
|
4 653
+49%
|
3 862
-17%
|
4 785
+24%
|
|
| Investing Cash Flow | |||||||||||||
| Capital Expenditures |
(592)
|
(608)
|
(1 428)
|
(1 377)
|
(460)
|
(394)
|
(273)
|
(180)
|
(220)
|
(448)
|
(442)
|
(293)
|
|
| Other Items |
(6 483)
|
(3 119)
|
(1 446)
|
4 977
|
(1 799)
|
(7 755)
|
(5 662)
|
755
|
1 294
|
2 849
|
(950)
|
(4 973)
|
|
| Cash from Investing Activities |
(7 076)
N/A
|
(3 727)
+47%
|
(2 874)
+23%
|
3 600
N/A
|
(2 259)
N/A
|
(8 149)
-261%
|
(5 935)
+27%
|
575
N/A
|
1 074
+87%
|
2 401
+124%
|
(1 392)
N/A
|
(5 266)
-278%
|
|
| Financing Cash Flow | |||||||||||||
| Net Issuance of Common Stock |
9 534
|
4 103
|
3 172
|
15
|
(43)
|
(105)
|
(63)
|
(58)
|
(77)
|
(36)
|
(1)
|
31
|
|
| Net Issuance of Debt |
(42)
|
(6)
|
(8)
|
3 841
|
3 841
|
(12)
|
(42)
|
(44)
|
(19)
|
(4 203)
|
(4 204)
|
(22)
|
|
| Cash Paid for Dividends |
(1 500)
|
(3 100)
|
(4 200)
|
(2 064)
|
(381)
|
(317)
|
(712)
|
0
|
(652)
|
0
|
(1 858)
|
0
|
|
| Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(6)
|
(9)
|
(3)
|
0
|
|
| Cash from Financing Activities |
7 993
N/A
|
997
-88%
|
(1 036)
N/A
|
1 791
N/A
|
3 417
+91%
|
(434)
N/A
|
(818)
-89%
|
(814)
+1%
|
(754)
+7%
|
(4 900)
-550%
|
(6 066)
-24%
|
(1 850)
+70%
|
|
| Change in Cash | |||||||||||||
| Effect of Foreign Exchange Rates |
133
|
168
|
(762)
|
(523)
|
(79)
|
(630)
|
(41)
|
149
|
(122)
|
(89)
|
(62)
|
(28)
|
|
| Net Change in Cash |
4 380
N/A
|
651
-85%
|
(2 282)
N/A
|
6 981
N/A
|
3 655
-48%
|
(5 945)
N/A
|
(4 053)
+32%
|
2 024
N/A
|
3 314
+64%
|
2 065
-38%
|
(3 658)
N/A
|
(2 359)
+36%
|
|
| Free Cash Flow | |||||||||||||
| Free Cash Flow |
2 737
N/A
|
2 604
-5%
|
963
-63%
|
736
-24%
|
2 117
+187%
|
2 873
+36%
|
2 468
-14%
|
1 934
-22%
|
2 897
+50%
|
4 204
+45%
|
3 421
-19%
|
4 492
+31%
|
|